The Neuroscience Report—Vol. 15 (August 10, 2015): Antipsychotic Medications

The latest in neuroscience—sorted and summarized for you Welcome to the Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. Volume 15 (August 10, 2015): Antipsychotic Medications Journal Articles Rationale for Iloperidone in the Treatment of Posttraumatic Stress Disorder Pseudoephedrine for the Treatment of Clozapine-Induced Incontinence Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method The Role of Long-acting Injectable Antipsychotics in Schizophrenia: A Critical Appraisal The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review   News Articles Positive Preclinical Results and Patent Allowed for Aequus’ Once-Weekly Transdermal Aripiprazole Otsuka, Lundbeck bag blockbuster FDA approval for antipsychotic Rexulti Antipsychotic Use Rising Among Teens and Young Adults New Analysis of Smoking and Schizophrenia Suggests Causal Link FDA Approves Invega Trinza, Four-times-a-year Treatment for Schizophrenia Wildcards Quantifying Clinical Relevance Summer and Antipsychotics in the City The Creativity Pill A History of the Ice Pick Lobotomy Anything to Avoid the Pain   Have a “supafly” week!  
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: Tags: Psychiatry Psychopharmacology Schizophrenia The Neuroscience Report antipsychotics Source Type: research